Implementation of Monitoring and management guidelines for second-generation antipsychoticsSERNYAK, Michael J.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 4, pp 14-18, 5 p.Article

Systemwide costs associated with second-generation antipsychotics in the treatment of schizophreniaSERNYAK, Michael J; ROSENHECK, Robert.Psychiatric services (Washington, D.C.). 2004, Vol 55, Num 12, pp 1361-1362, issn 1075-2730, 2 p.Article

Risk adjustment in studies using administrative dataSERNYAK, Michael J; ROSENHECK, Robert.Schizophrenia bulletin. 2003, Vol 29, Num 2, pp 267-271, issn 0586-7614, 5 p.Article

Clinicians' reasons for antipsychotic coprescribingSERNYAK, Michael J; ROSENHECK, Robert.The Journal of clinical psychiatry. 2004, Vol 65, Num 12, pp 1597-1600, issn 0160-6689, 4 p.Article

Use of system-wide Outcomes monitoring data to compare the effectiveness of atypical neuroleptic medicationsSERNYAK, Michael J; LESLIE, Douglas; ROSENHECK, Robert et al.The American journal of psychiatry. 2003, Vol 160, Num 2, pp 310-315, issn 0002-953X, 6 p.Article

Prescription of Second-Generation Antipsychotics: Responding to Treatment Risk in Real-World PracticeHERMES, Eric D. A; SERNYAK, Michael J; ROSENHECK, Robert A et al.Psychiatric services (Washington, D.C.). 2013, Vol 64, Num 3, pp 238-244, issn 1075-2730, 7 p.Article

Prescribers' nonadherence to treatment guidelines for schizophrenia when prescribing neurolepticsSERNYAK, Michael J; DAUSEY, David; DESAI, Rani et al.Psychiatric services (Washington, D.C.). 2003, Vol 54, Num 2, pp 246-248, issn 1075-2730, 3 p.Article

Impact of Clozapine on completed suicideSERNYAK, Michael J; DESAI, Rani; STOLAR, Marilyn et al.The American journal of psychiatry. 2001, Vol 158, Num 6, pp 931-937, issn 0002-953XArticle

Undiagnosed hyperglycemia in clozapine-treated patients with schizophreniaSERNYAK, Michael J; GULANSKI, Barbara; LESLIE, Douglas L et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 5, pp 605-608, issn 0160-6689, 4 p.Article

Prevalence of Concomitant Oral Antipsychotic Drug Use Among Patients Treated With Long-Acting, Intramuscular, Antipsychotic MedicationsKRISHAN AGGARWAL, Neil; SERNYAK, Michael J; ROSENHECK, Robert A et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 3, pp 323-328, issn 0271-0749, 6 p.Article

Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of SchizophreniaMOHAMED, Somaia; ROSENHECK, Robert; HARPAZ-ROTEM, Ilan et al.Psychiatric quarterly. 2009, Vol 80, Num 4, pp 241-249, issn 0033-2720, 9 p.Article

Impact of clozapine prescription on inpatient resource utilizationSERNYAK, Michael J; ROSENHECK, Robert; DESAI, Rani et al.The Journal of nervous and mental disease. 2001, Vol 189, Num 11, pp 766-773, issn 0022-3018Article

Use of the medication event monitoring system to estimate medication compliance in patients with schizophreniaDIAZ, Esperanza; LEVINE, Heidi B; SULLIVAN, Michelle C et al.Journal of psychiatry & neuroscience. 2001, Vol 26, Num 4, pp 325-329, issn 1180-4882Article